BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37036874)

  • 1. Artemisinin suppresses aerobic glycolysis in thyroid cancer cells by downregulating HIF-1a, which is increased by the XIST/miR-93/HIF-1a pathway.
    Yang F; Zhang J; Zhao Z; Liu Y; Zhao Z; Fu K; Li B; Jin J
    PLoS One; 2023; 18(4):e0284242. PubMed ID: 37036874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA XIST modulates HIF-1A/AXL signaling pathway by inhibiting miR-93-5p in colorectal cancer.
    Yang LG; Cao MZ; Zhang J; Li XY; Sun QL
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1112. PubMed ID: 32061057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of lncRNA XIST inhibits hypoxia-induced glycolysis, migration and invasion through regulating miR-381-3p/NEK5 axis in nasopharyngeal carcinoma.
    Zhao CH; Bai XF; Hu XH
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2505-2517. PubMed ID: 32196601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.
    Huang P; Mao LF; Zhang ZP; Lv WW; Feng XP; Liao HJ; Dong C; Kaluba B; Tang XF; Chang S
    Thyroid; 2018 May; 28(5):613-623. PubMed ID: 29634399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA XIST Promotes Migration and Invasion of Papillary Thyroid Cancer Cell by Modulating MiR-101-3p/CLDN1 Axis.
    Du YL; Liang Y; Cao Y; Liu L; Li J; Shi GQ
    Biochem Genet; 2021 Apr; 59(2):437-452. PubMed ID: 33057875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA XIST/miR-137 axis strengthens chemo-resistance and glycolysis of colorectal cancer cells by hindering transformation from PKM2 to PKM1.
    Zheng H; Zhang M; Ke X; Deng X; Li D; Wang Q; Yan S; Xue Y; Wang Q
    Cancer Biomark; 2021; 30(4):395-406. PubMed ID: 33386794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p.
    Hua G; Zeng ZL; Shi YT; Chen W; He LF; Zhao GF
    Pharmacology; 2021; 106(9-10):498-508. PubMed ID: 34352791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of lncRNA XIST inhibits cell proliferation via regulating miR-744/RING1 axis in non-small cell lung cancer.
    Wang J; Cai H; Dai Z; Wang G
    Clin Sci (Lond); 2019 Jul; 133(14):1567-1579. PubMed ID: 31292221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
    Hou S; Lin Q; Guan F; Lin C
    J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA XIST knockdown suppresses the growth of colorectal cancer cells via regulating microRNA-338-3p/PAX5 axis.
    Li W; He Y; Cheng Z
    Eur J Cancer Prev; 2021 Mar; 30(2):132-142. PubMed ID: 32826710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis.
    Liu X; Xie S; Zhang J; Kang Y
    Cancer Biother Radiopharm; 2020 Nov; 35(9):640-649. PubMed ID: 32191528
    [No Abstract]   [Full Text] [Related]  

  • 13. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
    Chen D; Chen T; Guo Y; Wang C; Dong L; Lu C
    Exp Cell Res; 2020 Nov; 396(1):112281. PubMed ID: 32919956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Long Non-Coding RNA XIST Interacted with MiR-124 to Modulate Bladder Cancer Growth, Invasion and Migration by Targeting Androgen Receptor (AR).
    Xiong Y; Wang L; Li Y; Chen M; He W; Qi L
    Cell Physiol Biochem; 2017; 43(1):405-418. PubMed ID: 28869948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA-XIST protects the hypoxia-induced cardiomyocyte injury through regulating the miR-125b-hexokianse 2 axis.
    Fan JL; Zhu TT; Xue ZY; Ren WQ; Guo JQ; Zhao HY; Zhang SL
    In Vitro Cell Dev Biol Anim; 2020 Apr; 56(4):349-357. PubMed ID: 32415544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
    Feng Z; Chen R; Huang N; Luo C
    Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non‑coding RNA XIST promotes cell proliferation of pancreatic cancer through miR‑137 and Notch1 pathway.
    Liu PJ; Pan YH; Wang DW; You D
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12161-12170. PubMed ID: 33336734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
    Liu Y; Chen G; Wang B; Wu H; Zhang Y; Ye H
    Endocr J; 2021 Jun; 68(6):713-727. PubMed ID: 33716239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR.
    Dong L; Geng Z; Liu Z; Tao M; Pan M; Lu X
    Pathol Res Pract; 2021 Sep; 225():153550. PubMed ID: 34340128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging roles of the long non-coding RNA 01296/microRNA-143-3p/MSI2 axis in development of thyroid cancer.
    Wang ZL; Wang C; Liu W; Ai ZL
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.